SCHEMBL1430122

SCHEMBL1430122

CC1CC2(CCN1Cc1ccc(O)c(-c3ccccc3Cl)c1)CN(C)S(=O)(=O)N2c1cccc(F)c1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171115 1.00 BACE1 (0.83) BACE1
SCHEMBL1171121 0.92 BACE1 (0.70) BACE1
SCHEMBL1170840 0.92 BACE1 (0.77) BACE1
SCHEMBL1429884 0.92 BACE1 (0.77) BACE1
SCHEMBL1429566 0.92 BACE1 (0.76) BACE1
SCHEMBL1170699 0.92 BACE1 (0.76) BACE1
SCHEMBL1429553 0.91 BACE1 (0.75) BACE1
SCHEMBL1170526 0.91 BACE1 (0.75) BACE1
SCHEMBL1170817 0.91 BACE1 (1.00) BACE1
SCHEMBL1429888 0.89 BACE1 (0.77) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300484-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Pfizer Inc. (US) 2011-03-30 EP claimed
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO claimed
EP-2300484-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Pfizer Inc. (US) 2011-03-30 EP disclosed
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO disclosed